日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacist-Led Management Improves Treatment Adherence and Quality of Life in Opioid-Tolerant Patients With Cancer Pain: A Randomized Controlled Trial

药师主导的管理可改善对阿片类药物耐受的癌症疼痛患者的治疗依从性和生活质量:一项随机对照试验

Zheng, Xiaowei; Ding, Haiying; Xu, Silu; Xie, Ruixiang; Liu, Yuguo; Zhai, Qing; Fang, Luo; Tong, Yinghui; Sun, Jiao; Xin, Wenxiu; Wu, Nan; Chen, Juan; Shi, Wenna; Yang, Ling; Li, Hui; Shao, Jingjing; Wang, Yangkui; Yu, Hui; Zhang, Bo; Du, Qiong; Yang, Yezi; Zhang, Xiaodan; Duan, Cunxian; Zhao, Qiulin; Shi, Jing; Huang, Jing; Fan, Qing; Cheng, Huawei; Chen, Lingya; Kong, Sisi; Zhang, Hui; Gong, Liyan; Zhang, Yiping; Song, Zhengbo; Yang, Yang; Zhou, Shoubing; Huang, Chengsuo; Lin, Jinyuan; Wang, Chenchen; Huang, Xianhong; Wei, Qing; Sun, Yancai; Huang, Ping

Genetic Variants in MTHFR Gene Predict ≥ 2 Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Patients Treated with Thoracic Radiotherapy

MTHFR基因的遗传变异预测接受胸部放射治疗的食管鳞状细胞癌患者发生≥2次放射性肺炎

Zhang, Yang; Li, Zongjuan; Zhang, Jian; Li, Hongsheng; Qiao, Yumei; Huang, Chengsuo; Li, Baosheng

Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro

抑制 p53 凋亡刺激蛋白 (iASPP) 的下调可在体外抑制顺铂耐药胃癌

Jianyong Yu, Li Li, Chengsuo Huang

Combination targeted therapy of VEGFR inhibitor, sorafenib, with an mTOR inhibitor, sirolimus induced a remakable response of rapid progressive Uterine PEComa

VEGFR抑制剂索拉非尼与mTOR抑制剂西罗莫司联合靶向治疗,对快速进展性子宫PEComa产生了显著疗效。

Gao, Fang; Huang, Chengsuo; Zhang, Yiping; Sun, Ruirui; Zhang, Yujie; Wang, Huijun; Zhang, Shu

Synthetic treatment of intracranial peripheral primitive neuroectodermal tumor with multiple metastasis: a case report

颅内周围原始神经外胚层肿瘤多发转移的综合治疗:病例报告

Zhang, Yang; Li, Hongsheng; Li, Zongjuan; Liu, Ming; Yang, Linke; Fan, Liyuan; Huang, Chengsuo; Li, Baosheng